<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="19" ids="28790">Serotonin</z:chebi> (<z:chebi fb="0" ids="28790">5-HT</z:chebi>), a well-known neurotransmitter of the central <z:mp ids='MP_0008912'>nervous</z:mp> system, has been implicated in diverse aspects of immune regulation </plain></SENT>
<SENT sid="1" pm="."><plain>Here we show that <z:chebi fb="0" ids="28790">5-HT</z:chebi> can efficiently drive programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> in established Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) lines that remain faithful to the original biopsy phenotype (group 1) </plain></SENT>
<SENT sid="2" pm="."><plain>Group 1 BL cells cultured in the presence of <z:chebi fb="0" ids="28790">5-HT</z:chebi> exhibited marked suppression of DNA synthesis that was accompanied by extensive <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-<z:chebi fb="19" ids="28790">serotonin</z:chebi>-driven <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was complete within 24 hours, was preceded by early caspase activation, and was accompanied by a decline in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells that had drifted to a lymphoblastic group 3 phenotype were relatively resistant to these actions of <z:chebi fb="19" ids="28790">serotonin</z:chebi>, and the forced ectopic expression of either bcl-2 or bcl-x(L) provided substantial protection from <z:chebi fb="0" ids="28790">5-HT</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="28790">5-HT</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> (SDZ205-557, granisetron, methysergide) failed to inhibit <z:chebi fb="19" ids="28790">serotonin</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, whereas the selective <z:chebi fb="19" ids="28790">serotonin</z:chebi> reuptake inhibitors (SSRI)-<z:chebi fb="0" ids="5118">fluoxetine</z:chebi> (<z:chebi fb="31" ids="5118">Prozac</z:chebi>), <z:chebi fb="0" ids="7936">paroxetine</z:chebi> (Paxil), and <z:chebi fb="0" ids="3723">citalopram</z:chebi> (<z:chebi fb="0" ids="3724">Celexa</z:chebi>)-substantially blocked the <z:chebi fb="3" ids="25375">monoamine</z:chebi> actions </plain></SENT>
<SENT sid="5" pm="."><plain>Western blot analysis showed that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells expressed protein for the <z:chebi fb="0" ids="28790">5-HT</z:chebi> transporter, and transport assays confirmed active uptake of <z:chebi fb="19" ids="28790">serotonin</z:chebi> by the cells </plain></SENT>
<SENT sid="6" pm="."><plain>Unlike what was suggested for neuronal cells, there was no evidence that intracellular oxidative metabolites were responsible for the <z:chebi fb="0" ids="28790">5-HT</z:chebi>-induced programmed <z:hpo ids='HP_0011420'>death</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>These data indicate that <z:chebi fb="19" ids="28790">serotonin</z:chebi> drives <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in biopsylike <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells after its entry through an active transport mechanism, and they suggest a novel therapeutic modality for Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>